A Case Report of Leukocytosis During Modified Electroconvulsive Therapy of Paranoid Personality Disorder.

Introduction: Modified electroconvulsive therapy (MECT) is a viable therapeutic option for patients with mood disorders and schizophrenia. We found that there is a relationship between MECT and leukocytosis. To the best of our knowledge, this is the first case of this problem.

Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

The prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM) is increasing and there is an urgent need for new treatment strategy to prevent progression of hepatic steatosis and fibrosis. We have performed a systematic review and meta-analysis of randomized controlled trials (RCTs) to evaluate the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the treatment of hepatic steatosis and fibrosis in patients with T2DM and NAFLD. The PubMed, Web of Science, Scopus, Embase and Cochrane Central Register of Controlled Trials databases were searched for articles that met the eligibility criteria to explore the efficacy and safety of GLP-1RAs in patients with T2DM and NAFLD.

The dependence of the β-to-α phase transition behavior of poly(1,4-butylene adipate) on phase separated morphology in its blends with poly(vinylidene fluoride).

Synchrotron wide-angle X-ray diffraction was used to monitor the melting and β-to-α transition behavior of β-poly(1,4-butylene adipate) (β-PBA) and its blends with poly(vinylidene fluoride) (PVDF). Two kinds of typical phase separated morphologies are prepared: interfabrillar (70/30 PBA/PVDF) and interlamellar (50/50 PBA/PVDF) morphologies. After melt recrystallization at 10 °C, β-PBA crystals are obtained.